الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 151 |  |  |
| | | from | 151 | | |
Abstract
Jara MAG, Mora Hidalgo A, Avalos Gulin JC, López Albiach M, Muñoz Ortiz L, Torán Monserrat P and Esteva Ollé X (2013): Exposure of health workers in primary health care to glutaraldehyde. Journal of Occupational Medicine and Toxicology ; 8:31. Available at: http://occup-med.biomedcentral.com/articles/10.1186/1745-6673-8-31
Jordan SLP, Stowers MF, Trawick EG, and Theis AB (1996): Glutaraldehyde permeation, choosing the proper glove. Am J Infect Control; 24(2):67-69.
K
Katagiri H, Suzuki T, Aizawa Y and Kadowaki T (2006): Indoor Glutaraldehyde Levels in the Endoscope Disinfecting Room and Subjective Symptoms among Workers. Industrial Health; 44:225–229.
Keynes HL, Ross DJ and McDonald JC (1996): Surveillance of work-related and occupational respiratory disease in the U.K. Occup Med; 46(5):379-381.
Kovaleva J and Buss A (2011): Usefulness of Bacteriological Monitoring of Endoscope Reprocessing. Available at: http://www.intechopen.com///usefulness-of-bacteriological-monitoring-of-endoscope-reprocessing
Kovaleva J, Meessen NE, Peters FT, Been MH, Arends JP, Borgers RP and Degener JE(2009): Is bacteriologic surveillance in endoscope reprocessing stringent enough? Endoscopy; 41:913–916.
Kovaleva J, Peters FTM, Van der Mei HC and Degener JE (2013): Transmission of Infection by Flexible Gastrointestinal Endoscopy and Bronchoscopy. Clin. Microbiol. Rev.; 26(2): 231-254.
L
Leinster P, Baum JM and Baxter PJ (1993): An assessment of exposure to glutaraldehyde in hospitals: Typical exposure levels and recommended control measures. British Journal of Industrial Medicine; 50:107-111.
Liss GM, Tarlo SM, Doherty J, Purdham J, Greene J, McCaskell L and Kerr M (2003): Physician diagnosed asthma, respiratory symptoms, and associations with workplace tasks among radiographers in Ontario, Canada. Occup Environ Med; 60:254-261.
Loukili NH, Granbastien B, Faure K, Guery B and Beaucaire G (2006): Effect of different stabilized preparations of peracetic acid on biofilm. J. Hosp. Infect. ; 63:70–72.
M
Maestrelli P, Occari P, Turato G, Papiris SA, Di Stefano A, Mapp CE, Milani GF, Fabbri LM and Saetta M (1997): Expression of interleukin (IL)-4 and IL-5 proteins in asthma induced by toluene diisocyanate (TDI). Clin Exp Allergy; 27(11):1292-1298.
Marion-Ferey K, Pasmore M, Stoodley P, Wilson S, Husson GP and Costerton JW( 2003): Biofilm removal from silicone tubing: an assessment of the efficacy of dialysis machine decontamination procedures using an in vitro model. J. Hosp. Infect.; 53:64–71.
Martini A, Iavicoli S and Corso L (2013): Multiple chemical sensitivity and the workplace: current position and need for an occupational health surveillance protocol. Oxid Med Cell Longev.; vol.2013, Article ID 351457, 13 pages. doi:10.1155/2013/351457.
Mayoclinic (2015): Diseases and Conditions, Asthma attack. [Cited Nov. 2015]. Available at: http://www.mayoclinic.org/diseases-conditions/asthma-attack/multimedia/asthma-attack/img-20008649
McCarthy K (2015): Pulmonary Function Testing. Available at: http://emedicine.medscape.com/article/303239-overview
McDonnell G and Russell AD (1999): Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev; 12:147–179.
McGinley HR (2013): Glutaraldehyde Uses and Counterfeits. Available at: http://www.adhesivesmag.com/articles/91766-glutaraldehyde-uses-and-counterfeits
Medicine Net (2015): Asthma overview article. Available at: http://www.medicinenet.com/asthma_overview/article.htm
Mehta AC, Prakash UBS, Garland R, Haponik E, Moses L, Schaffner W and Silvertri G (2005): Prevention of flexible bronchoscopy-associated infection. Chest; 128(3):1742-1755.
Menzies D (1995): Glutaraldehyde-controlling the risk to health. British Journal of Theatre Nursing; 4, 11, 13-15.
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G and Wanger J (2005): Standardisation of spirometry. Series ‘‘ATS/ERS Task force: Standardisation of lung function testing’’. Eur Respir J; 26: 319–338. Available at: https://www.thoracic.org/statements/resources/pfet/PFT2.pdf
Miyajima K, Tabuchi T and Kumagai S (2006): Occupational health of endoscope sterilization workers in medical institutions in Osaka Prefecture. Sangyo Eiseigaku Zasshi. ; 48(5):169-175.
MRC (Medical Research Council) (1986): Respiratory Symptoms questionnaire. London, England: British Medical Research Council.
Muscarella LF (2000): Automatic flexible endoscope reprocessors. Gastrointest Endosc Clin N Am.; 10(2):245-257.
N
Nayebzadeh A (2007): The effect of work practices on personal exposure to glutaraldehyde among health care workers. Ind Health; 45: 289–295.
Nelson D (2000): Newer technologies for endoscope disinfection: electrolyzed acid water and disposable-component endoscope systems. Gastrointes.Endosc.Clin.N.AM; 10:319-328.
Nelson DB, Barkun AN, Block KP, Burdick JS, Ginsberg GG, Greenwald DA, Kelsey PB, Nakao NL, Slivka A, Smith P and Vakil N (2001) : Technology status evaluation report. Transmission of infection by gastrointestinal endoscopy. Gastrointest. Endosc. ; 54:824–828.
Nelson DB, Jarvis WR, Rutala WA, Foxx-Orenstein AE, Isenberg G, Dash GR, Alvarado CJ, Ball M, Griffin-Sobel J, Petersen C, Ball KA, Henderson J and Stricof RL (2003): Society for Health care Epidemiology of America. Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Infect. Control Hosp. Epidemiol. ; 24:532–537.
NICNAS (National Industrial Chemical Notification and Assessments Scheme) (1994): Priority Existing Chemical No. 3, Glutaraldehyde, Full Public Report available at: http://www.nicnas.gov.au/publications/CAR/PEC/ PEC3/PEC3index.htm
NIOSH (National Institute for Occupational Safety and Health) (2001): Glutaraldehyde, Occupational Hazards in Hospitals. DHHS (NIOSH) Publication No. 2001-115. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Cincinnati, OH. Available at: http://www.cdc.gov/niosh/docs/2001-115/
NIOSH (The National Institute for Occupational Safety and Health) (2014): personal protective equipment (PPE) for use with glutaraldehyde exposures. [Cited 2014 July12]. Available at: http://www.cdc.gov/niosh/docket/archive/pdfs/NIOSH-159/0159-020109-Sheet407.pdf
Norbäck D (1988): Skin and respiratory symptoms from exposure to alkaline glutaraldehyde in medical services Scand J Work Environ Health. ; 14(6):366-371.
Noy MF, Harrison L, Holmes GK and Cockel R (1980): The significance of bacterial contamination of fiberoptic endoscopes. J. Hosp. Infect.; 1:53–61.
NSW Health Department (1993): Guidelines for the safe use of Glutaraldehyde in Health Care Establishment. Available at: http://www.health.nsw.gov.au/fcsd/rmc/cib/circulars/1993/cir93-99.pdf
O
O’Brien HA, Mitchell JD, Haberman S, Rowan DF, Winford TE and Pellet J(1966): The use of activated glutaraldehyde as a cold sterilizing agent for urological instruments. J Urol.; 95:429–435.
OHSrep (Occupational Health and Safety representatives) (2015): Glutaraldehyde. Available at: http://www.ohsrep.org.au/hazards/chemicals/glutaraldehyde
OSHA (Occupational Safety and Health Administration) (2006): Best practice for the safe use of glutaraldehyde in health care. Available at: https://www.osha.gov/Publications/glutaraldehyde.pdf
OSHA (Occupational Safety and Health Administration) (2015): Healthcare Wide Hazards, Gluteraldehyde. U.S. Department of Labor; [cited May 2015]. Available at: https://www.osha.gov/SLTC/etools/hospital/hazards/glutaraldehyde/glut.html
OSHA (Occupational Safety and Health Administration) (2015): Eye and Face Protection eTool, selection of PPE for the workplace [cited July 2015]. Available at: https://www.osha.gov/SLTC/etools/eyeandface/ppe/chemicals.html
P
Pcimedical (2015): Ventilation Standards for OPA, Glutaraldehyde, and Hydrogen Peroxide [cited Sep. 2015]. Available at: http://blog.pcimedical.com/press-content/bid/79550/Ventilation-Standards-for-OPA-Glutaraldehyde-and-Hydrogen-Peroxide
Pineau L, Villard E, Duc DL and Marchetti B (2008): Endoscope drying/storage cabinet: interest and efficacy. J. Hosp. Infect.; 68:59–65.
Pisaniello DL, Gun RT, Tkaczuk M N and Nitshcke M and Crea J (1997) : Glutaraldehyde Exposures and Symptoms among Endoscopy Nurses in South Australia. Applied Occupational and Environmental Hygiene ; 12:3, 171-177.
Pryor PD (1984): National Jewish Hospital, Denver, Colorado. NIOSH Health Hazard Evaluation Report No. 83-074-1525.
Q
Queensland Health (2011): Endoscope reprocessing. Module 3 , Workplace health and safety. Risk assessment-Glutaraldehyde Available at: https://www.health.qld.gov.au/EndoscopeReprocessing/module_3/3_5.asp
R
Rejchrt S, Cermák P, Pavlatová L, Micková E and Bures J. (2004): Bacteriologic testing of endoscopes after high-level disinfection. Gastrointest. Endosc. ; 60:76–78.
Rideout K, Teschke K, Dimich-Ward H and Kennedy SM (2005): Considering risks to healthcare workers from glutaraldehyde alternatives in high-level disinfection. Journal of Hospital Infection; 59: 4–11.
Rodríguez Pérez AU, Delgado Pérez ML and Dujarric Martínez MD (2007): Antimicrobial procedures. Part I: disinfection in health institutions Rev. Cubana Hig Epidemiol ; 45(2).
Romano-Woodward D (2000): Safe use of glutaraldehyde. Nursing Standard; 14(32): 47-51.
Rosenman KD, Reilly MJ and Kalinowski DJ (1997): A state-based surveillance system for work-related asthma. J Occup Environ Med, 39(5):415-425.
Russell AD (1990): Bacterial Spores and Chemical Sporicidal Agents. Clinical Microbiology Reviews; 3(2):99-119.
Russell AD and Hopwood D (1976): The biological uses and importance of Glutaraldehyde. Prog Med Chem.; 13:271-301.
Rutala WA and Weber DJ (1999): Disinfection of endoscopes: review of new chemical sterilants used for high-level disinfection. Infect. Control Hosp. Epidemiol.; 20:69-76.
Rutala WA and Weber DJ (2013): Disinfection and sterilization: an overview. Am J Infect Control ; 41: S2-S5.
Rutala WA, Weber DJ and the Healthcare Infection Control Practices Advisory Committee (HICPAC) (2008): Guideline for Disinfection and Sterilization in Healthcare Facilities. Available at: http://www.cdc.gov/hicpac/pdf/guidelines/Disinfection_Nov_2008.pdf
S
Sanderson KV and Cronin E (1968): Glutaraldehyde and contact dermatitis. Br Med J; 3:802.
Schembre DB (2000): Infectious complications associated with gastrointestinal endoscopy. Gastrointest Endosc Clin N Am.; 10(2):215-32.
Shaffer MP and Belsito DV(2000): Allergic contact dermatitis from glutaraldehyde in health-care workers. Contact Dermatitis; 43: 150–156.
Silva CV, Magalhães VD, Pereira CR, Kawagoe JY, Ikura C and Ganc AJ (2003): Pseudo-outbreak of Pseudomonas aeruginosa and Serratia marcescens related to bronchoscopes. Infect. Control Hosp. Epidemiol.; 24:195–197.
Simmons BP (1983): CDC guidelines for the prevention and control of nosocomial infection. Guideline for hospital environmental control. Am. J. Infect. Control; 11:97–120.
Smith DR (2000): Airborne glutaraldehyde levels : Perceptions versus risk. J Occup Health Safety. Aust NZ; 16:233-236.
Smith DR (2001): Self-reported glutaraldehyde symptoms : Are they an accurate predictor of workplace risk? J Occup Health Safety.Aust NZ; 17:287-293.
Smith DR and Wang RS (2006): Glutaraldehyde exposures and its occupational impact in the health care environment. Environ Health Prev Med; 11: 3–10.
Sokol WN (2004): Nine episodes of anaphylaxis following cystoscopy caused by Cidex OPA (orthophthalaldehyde) high-level disinfectant in 4 patients after cytoscopy. J Allergy Clin Immunol; 114(2):392–397.
Spaulding EH and Gröschel DH (1974): Hospital disinfectants and antiseptics, p 852–857 In Lennette EH, Spaulding EH, Truant JP, editors. (ed), Manual of clinical microbiology, 2nd ed American Society for Microbiology, Washington, DC.
Spi (2015): Spi supplies. Eye protection. Available at: http://www.2spi.com/category/eye-protection/
Srinivasan A (2003): Epidemiology and prevention of infections related to endoscopy. Curr. Infect. Dis. Rep.; 5:467–472.
Stenton SC, Beach JR, Dennis JH, Keaney NP and Hendrick DJ(1994): Glutaraldehyde, asthma and work--a cautionary tale. ; 44(2):95-98.
Stonehill AA, Krop S and Borick PM (1963): Buffered glutaraldehyde. A new chemical sterilizing solution. AM J Hosp Pharm; 20:458-465.
Stony Brook University (2008): Glutaraldehyde Fact sheet, Health and safety information, EHSD0095 .Available at: www.stonybrook.edu/ehs
Sutton P,Quint J, Prudhomme J, Flattery J, Materna B and Harrison R(2007): Glutaraldehyde exposures among workers making bioprosthetic heart valves. J Occup Environ Hyg; 4:311–320.
T
Takigawa T, Horike T, Ohasi Y, Kataoka H, Wang DH and Kira S (2004):were volatile organic compounds the inducing factors for subjective symptoms of employees working in newly constructed hospitals? Environ Toxicol ;19: 280-290.
Takigawa T and Endo Y (2006): Effects of glutaraldehyde exposure on human health. J Occup Health ; 48: 75–87.
Tumpowsky CM (1997): Respiratory Effects of Glutaraldehyde Exposure. SENSOR Occupational Lung Disease Bulletin ; Massachusetts Department of Public Health, Occupational Health Surveillance Program. Available at: http://www.mass.gov/eohhs/docs/dph/occupational-health/sensor-lung-disease-bulletins/astbull-jun97.pdf
Tyler R, Ayliffe GAJ and Bradley CR (1990): Virucidal Activity of disinfectants.Study with the polio virus. J Hosp Infect; 339-345.
U
Uddin R (2015): Cidex side effects. Available at: http://www.livestrong.com/article/123783-cidex-side-effects/
V
Vyas A, Pickering CAC, Oldham LA, Francis HC, Fletcher AM , Merrett T and Niven R McL(2000) : Survey of symptoms, respiratory function, and immunology and their relation to glutaraldehyde and other occupational exposures among endoscopy nursing staff. Occup Environ Med; 57:752-759.
W
Waters A, Beach J and Abramson M (2003): Symptoms and lung function in health care personnel exposed to glutaraldehyde. Am J Ind Med ; 43: 196–203.
Weber DJ and Rutala WA (2001): Use of metals as microbicides in preventing infections in healthcare. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins; 415- 430.
Weekes J (2012): How the hierarchy of control can help you fulfill your health and safety duties. Available at: http://www.healthandsafetyhandbook.com.au/how-the-hierarchy-of-control-can-help-you-fulfil-your-health-and-safety-duties/
Y
Yeshnowski M (2004): Minimizing Glutaraldehyde Use. Tetra Tech EM Inc. Available at: http://wsppn.org/pdf/hospital/11%20Minimizing%20Glut%20(AZ).pdf
Z
Ziem G and McTamney J (1997): Profile of patients with chemical injury and sensitivity. Environ Health Perspect (Supply 2); 417-436.